Adial Pharmaceuticals, Inc. (ADIL) vs Moleculin Biotech, Inc. (MBRX)
Adial Pharmaceuticals, Inc. and Moleculin Biotech, Inc. are both Biotechnology companies. Adial Pharmaceuticals, Inc. and Moleculin Biotech, Inc. are of similar size ($11.3M and $11.2M). Adial Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.1×. Across the 9 metrics below, Adial Pharmaceuticals, Inc. leads on 5 and Moleculin Biotech, Inc. on 4.
Valuation
Profitability
| Metric | ADIL | MBRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 352.60% | (1,471.05%) | (57.72%) |
| Return on assets | (322.10%) | (152.41%) | (49.22%) |
| Return on invested capital | 0.00% | (417.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack